The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical, molecular, and immunologic profiling of brain metastases (BM) in head and neck squamous cell carcinoma (HNSCC).
 
Michael J. Dennis
Consulting or Advisory Role - MJH Life Sciences
 
Dean Pavlick
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Alec Kacew
No Relationships to Disclose
 
Michael Wotman
No Relationships to Disclose
 
Stephanie M Jones
No Relationships to Disclose
 
Kathleen L. Pfaff
Employment - Dana-Farber Cancer Institute
Patents, Royalties, Other Intellectual Property - receive royalties for patent on a high content screening assay for iPSC-derived motor neuron survival (work done prior to joining DFCI)
 
Scott J. Rodig
Leadership - Immunitas
Stock and Other Ownership Interests - Immunitas
Honoraria - Bristol-Myers Squibb; Perkin Elmer
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Affimed Therapeutics; Bristol-Myers Squibb; Kite, a Gilead company; Merck
Patents, Royalties, Other Intellectual Property - Patent pending for use of Anti-galectin1 antibodies for diagnostic use.
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Emily Reister
Employment - Phase Genomics, Inc.
 
Maika Malig
Employment - Phase Genomics, Inc.
 
Stephen Eacker
Employment - Phase Genomics
 
David Eric Piccioni
No Relationships to Disclose
 
Santosh Kesari
Stock and Other Ownership Interests - Curtana; Praesidia; xcures
Honoraria - Jubilant Biosys; Pyramid Biosciences
Consulting or Advisory Role - biocept; iCAD; xcures
Research Funding - AIVITA Biomedical, Inc. (Inst); Bayer (Inst); Biocept (Inst); Blue Earth Diagnostics (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Caris MPI (Inst); cns pharmaceuticals (Inst); EpicentRx (Inst); Lilly (Inst); Oblato (Inst); Orbus therapeutics (Inst)
 
Kartik Sehgal
Honoraria - AmerisourceBergen; Binacea; Medscape; Pri-Med
Consulting or Advisory Role - Equinox Group; Exelixis; Guidepoint Global; Medscape; Scholar Rock
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Binacea; Merck; Pri-Med
 
Robert I. Haddad
Employment - Dana-Farber Cancer Institute
Leadership - NCCN
Stock and Other Ownership Interests - tosk
Consulting or Advisory Role - ALX Oncology; AstraZeneca; aveo; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Coherus Biosciences; Eisai; EMD Serono; Galera Therapeutics; Genmab; GlaxoSmithKline; Merck; Merus; PDS Biotechnology; Scholar Rock
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); Incyte (Inst); Kura Oncology (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Boehringer Ingelheim; Hookipa Pharma; ISA Pharmaceuticals; Nanobiotix
 
Ezra Cohen
Employment - Tempus
 
Marshall R. Posner
Honoraria - Naveris
Consulting or Advisory Role - Aveo; Calliditas Therapeutics; Galeria; Merck; Merus
Research Funding - BioNTech (Inst); Flamingo Pharma (Inst); Gilead Sciences (Inst); Hookipa Pharma (Inst); ISA Pharmaceuticals (Inst); Regeneron (Inst); Toragen (Inst)
Patents, Royalties, Other Intellectual Property - anti-Staphylococcal Monoclonal antibody (Inst); Uptodate editor
(OPTIONAL) Uncompensated Relationships - Frizent; Vivan Therapeutics
 
Ida Deichaite
No Relationships to Disclose
 
Glenn J. Hanna
Employment - Dana-Farber Cancer Institute
Honoraria - Massachusetts Medical Society
Consulting or Advisory Role - Bicara Therapeutics; Boxer Capital; Bristol-Myers Squibb; Coherus Biosciences; Coherus Biosciences; Elevar Therapeutics; Grey Wolf Therapeutics; InhibRx; KSQ Therapeutics; Kura Oncology; Merck; Naveris; Nextech Invest; PDS Biotechnology; Remix Therapeutics; Replimune; Surface Oncology
Research Funding - Actuate Therapeutics (Inst); Adenoid Cystic Carcinoma Research Foundation (Inst); ASCO (Inst); Bicara Therapeutics (Inst); Bristol-Myers Squibb (Inst); Gateway for Cancer Research; Genentech (Inst); ImmunityBio (Inst); Kura Oncology (Inst); Regeneron (Inst); Secura Bio (Inst)